Ding dong ding dong

Hahaha...sabar..

Tidur banyak lama la

Lain semua merah...ini green...power... buy more..haha

Di kala kita bergembira...ingatlah ada rakan kita sedang berduka di glove kaunter sana...haha

Bawang oh bawang...

Glove makers dominate list of top losers as vaccine roll-out begins.

Glove makers dominate list of top losers as vaccine roll-out begins

Glove makers dominate list of top losers as vaccine roll-out begins

Jadi la dapat lunch nasi ayam...haha

History ka apa ka...itu saya tak kisah...haha

Muar: Perdana Menteri, Tan Sri Muhyiddin Yassin, sudah mengarahkan supaya bekalan vaksin Covid-19 segera ditambah sehingga 70 peratus daripada keseluruhan populasi negara.

Muhyiddin berkata, penambahan vaksin sehingga 70 peratus itu juga dinasihat dan disarankan Kementerian Kesihatan (KKM).

"Saya juga sudah arahkan Menteri Kesihatan, Datuk Seri Dr Adham Baba dan Menteri Sains, Teknologi dan Inovasi, Khairy Jamaluddin Abu Bakar, untuk berunding dan dapatkan bekalan vaksin Covid-19 sehingga 60 atau 70 peratus daripada jumlah populasi rakyat kita.

"Sekarang Malaysia sudah dapatkan 30 peratus vaksin Covid-19, namun bagi saya ia tidak mencukupi.

Tomorrow open 0.170....wang besar haha

Tiba2 semua berita negative keluar….

BATU KAWAN: Iconic Worldwide Bhd aims to become a leading glove maker in the world following its investment of RM155 million for a new personal protective equipment (PPE) manufacturing plant here in Penang.

Its managing director Datuk Tan Kean Tet said the group's wholly-owned subsidiary, Iconic Medicare Sdn Bhd, intends to manufacture and trade latex and nitrile gloves for household, industrial and medical use, as well as two main types of disposable face masks.

"According to the Malaysian Rubber Glove Manufacturers Association, the world demand for gloves is estimated to be 33 billion pieces a year and after the completion of our new manufacturing facility, we are capable of producing 3.3 billion pieces of gloves, which is equivalent to one per cent of the global demand.

"The demand for gloves has been on the rise of 10 per cent per annum pre-COVID, but it is expected to rise over 30 per cent per annum due to the pandemic. We have set our sights on producing 17 billion pieces of gloves which commands a global share of approximately five per cent," he said.

Tan said this at the ground breaking ceremony of Iconic Medicare's PPE manufacturing facility by Chief Minister Chow Kon Yeow here today.

He said the new facility will be installing and commissioning glove and disposable face mask production lines which are expected to yield a minimum production capacity of approximately 330 billion pieces of gloves and approximately 220 million pieces of face mask per annum.

"We expect the glove production to generate a potential revenue of RM1 billion a year while the production of disposable mask is expected to generate a potential revenue of RM100 million per annum once it's fully operational.

"In total, Iconic Worldwide is expected to generate a potential gross profit of RM450 million a year," he said.

He said the new manufacturing facility sited on 2.2 hectares is scheduled to be completed in July next year and operational in September 2021

KUALA LUMPUR, Dec 12 — Malaysia will not rush the approval of Covid-19 vaccines for “emergency use” as some other nations have done, said Khairy Jamaluddin.

The Science, Technology and Innovation minister said the country would ensure that any vaccines procured would go through thorough evaluation by the authorities to ensure their safety.

“In Malaysia, there will be no political pressure and we will not use the emergency-use pathway.

“The clinical data of the vaccines we procure will be independently evaluated by the [Health Ministry’s National Pharmaceutical Regulatory Agency] NPRA before it can be registered and used,” he said.

The minister was commenting on a report of the US Food and Drug Administration expediting approval for the Pfizer-Biontech vaccine due to pressure from the outgoing Trump administration.

Donald Trump is pushing for the vaccine to be rolled out before the formal transition to President-Elect Joe Biden next year in order to claim credit for his administration.

Malaysia has ordered the Pfizer-Biontech vaccine and an alternative from COVAX that would roughly cover 30 per cent of the population, which will be delivered in batches next year.

However, no country has yet given full regulatory approval to any Covid-19 vaccine candidate so far.

This has led to some sections here in Malaysia and elsewhere to express concern over the potential dangers and side effects that may have been overlooked in the rush to produce a reliable vaccine against the world-stopping Covid-19 pandemic.

The Health Ministry has repeatedly assured Malaysians that any and all vaccines to be used here will be fully studied and evaluated to ensure they are safe to use.

Malaysia is grappling with a third wave of Covid-19 infections that has pushed the country’s total cases to over 80,000.

KUALA LUMPUR, Dec 12 — Malaysia will not rush the approval of Covid-19 vaccines for “emergency use” as some other nations have done, said Khairy Jamaluddin.

The Science, Technology and Innovation minister said the country would ensure that any vaccines procured would go through thorough evaluation by the authorities to ensure their safety.

“In Malaysia, there will be no political pressure and we will not use the emergency-use pathway.

“The clinical data of the vaccines we procure will be independently evaluated by the [Health Ministry’s National Pharmaceutical Regulatory Agency] NPRA before it can be registered and used,” he said.

The minister was commenting on a report of the US Food and Drug Administration expediting approval for the Pfizer-Biontech vaccine due to pressure from the outgoing Trump administration.

Donald Trump is pushing for the vaccine to be rolled out before the formal transition to President-Elect Joe Biden next year in order to claim credit for his administration.

Malaysia has ordered the Pfizer-Biontech vaccine and an alternative from COVAX that would roughly cover 30 per cent of the population, which will be delivered in batches next year.

However, no country has yet given full regulatory approval to any Covid-19 vaccine candidate so far.

This has led to some sections here in Malaysia and elsewhere to express concern over the potential dangers and side effects that may have been overlooked in the rush to produce a reliable vaccine against the world-stopping Covid-19 pandemic.

The Health Ministry has repeatedly assured Malaysians that any and all vaccines to be used here will be fully studied and evaluated to ensure they are safe to use.

Malaysia is grappling with a third wave of Covid-19 infections that has pushed the country’s total cases to over 80,000.

KUALA LUMPUR, Dec 12 — Malaysia will not rush the approval of Covid-19 vaccines for “emergency use” as some other nations have done, said Khairy Jamaluddin.

The Science, Technology and Innovation minister said the country would ensure that any vaccines procured would go through thorough evaluation by the authorities to ensure their safety.

“In Malaysia, there will be no political pressure and we will not use the emergency-use pathway.

“The clinical data of the vaccines we procure will be independently evaluated by the [Health Ministry’s National Pharmaceutical Regulatory Agency] NPRA before it can be registered and used,” he said.

The minister was commenting on a report of the US Food and Drug Administration expediting approval for the Pfizer-Biontech vaccine due to pressure from the outgoing Trump administration.

Donald Trump is pushing for the vaccine to be rolled out before the formal transition to President-Elect Joe Biden next year in order to claim credit for his administration.

Malaysia has ordered the Pfizer-Biontech vaccine and an alternative from COVAX that would roughly cover 30 per cent of the population, which will be delivered in batches next year.

However, no country has yet given full regulatory approval to any Covid-19 vaccine candidate so far.

This has led to some sections here in Malaysia and elsewhere to express concern over the potential dangers and side effects that may have been overlooked in the rush to produce a reliable vaccine against the world-stopping Covid-19 pandemic.

The Health Ministry has repeatedly assured Malaysians that any and all vaccines to be used here will be fully studied and evaluated to ensure they are safe to use.

Malaysia is grappling with a third wave of Covid-19 infections that has pushed the country’s total cases to over 80,000.

Tomorrow you buy lo...hahaha

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over...

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over.
KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Bawang sapu keliling...

Malam dia green...siang dia red...susah la ini macam.

Tomorrow see first...ini share berat atau tidak...harap ozura tak kacau.

KUALA LUMPUR (Dec 10): Inix Technologies Holdings Bhd’s former chairman Wan Kuok Koi has been blacklisted by the US due to his activities at the helm of the 14K Triad, according to a report.

Reuters reported that the US had slapped sanctions on Wan, who is the leader of the organised crime group involved in drug trafficking, illegal gambling, racketeering, human trafficking and other criminal activities.

He is also reportedly a member of the Chinese Communist Party’s (CCP) Chinese People’s Political Consultative Conference (CPPCC).

It has been more than a week since the 2020 US presidential election has been called, and although the results have yet to be officially certified by the electoral college...
Read More
The US Treasury also designated three entities owned or controlled by Wan, namely Cambodia-based World Hongmen History and Culture Association, Hong Kong-based Dongmei Group and the Palau China Hung-mun Cultural Association in Palau.

“It said the World Hongmen group had co-opted elites in Malaysia and Cambodia, continuing a 'pattern of overseas Chinese actors trying to paper over illegal criminal activities by framing their actions in terms of China’s Belt and Road Initiative (BRI)' and other major initiatives of the CCP,” the wire reported.

His properties that fall under US jurisdiction are frozen under the sanctions.

The Macau billionaire, better known by his gang moniker "Broken Tooth Koi", was appointed the independent and non-executive chairman of Inix in August this year.

He was released from the prison in Macau in December 2012 after serving a 14-year sentence for charges including loan-sharking, money laundering and heading a criminal group, news reports said.

The 65-year-old was the dragon head, or leader, of the infamous 14K Triad operating out of Macau, according to news reports, although his reach spanned many parts of Europe.

Meanwhile at Inix, after a short stint of four months, he resigned from his post on Dec 2. On the same day, Inix announced the appointment of Tan Sri Mohamad Fuzi Harun, a retired inspector-general of the Royal Malaysia Police, as its independent and non-executive chairman, although he, too, resigned from his role a mere five days after the appointment.

Post removed.Why?

Ini betul2 bikin hati panas....malam dia hijau...siang dia merah...haha

Ini bawang profesional punya...dia makan habis semua...haha

Buy more...ready to fly...haha

Post removed.Why?

Jeng..jeng..jeng...kasi pecah 1900

I sudah 10 round pun diam saja...haha

Sabar...sabar...haha

Gold price trading higher...cantik!

Harap boleh sampai 0.40 memang cantik...Christmas gift..haha

Apa yg ko merepek ni...haha

Post removed.Why?

Hero selalu datang last minit!

Sapu la apa tunggu...haha

Petang ini mau makan satu lorry la..haha

Sabar bang...sabar...

Bawang...bawang...bawang...

Sapuuuuuuuuuuuuuuuuuuuuuuuu

Sabar...haha